Table 5
Palliation of symptoms during the first 16 weeks after randomisation*
| Nature of palliation† | ASC only | ASC plus chemotherapy | ||
|---|---|---|---|---|
| Assessable | Palliated | Assessable | Palliated | |
| *This analysis was based on clinicians’ assessments from which more data were available than from the questionnaires, but the results are very similar to those from the patient questionnaires. | ||||
| †Defined in the text. | ||||
| Chest pain | ||||
| Improvement | 9 | 2 | 22 | 12 |
| Control | 7 | 2 | 26 | 16 |
| Prevention | 2 | 1 | 36 | 16 |
| Total palliated | 18 | 5 (28%) | 84 | 44 (52%) |
| Breathlessness | ||||
| Improvement | 7 | 0 | 24 | 7 |
| Control | 9 | 1 | 29 | 14 |
| Prevention | 2 | 1 | 16 | 2 |
| Total palliated | 18 | 2 (11%) | 83 | 23 (28%) |
| Anorexia | ||||
| Improvement | 4 | 0 | 12 | 7 |
| Control | 4 | 4 | 11 | 6 |
| Prevention | 10 | 4 | 61 | 30 |
| Total palliated | 18 | 8 (44%) | 84 | 43 (51%) |
| Sweating attacks | ||||
| Improvement | 4 | 2 | 18 | 9 |
| Control | 3 | 3 | 19 | 12 |
| Prevention | 11 | 7 | 47 | 32 |
| Total palliated | 18 | 12 (67%) | 84 | 53 (63%) |
